Literature DB >> 2880397

Tetrahydroprotoberberine--a new chemical type of antagonist of dopamine receptors.

G Z Jin, X L Wang, W X Shi.   

Abstract

In rats lesioned by unilateral micro-injection of 6-OHDA into substantia nigra, the apomorphine-induced contralateral rotation and the amphetamine-induced ipsilateral rotation were antagonized by THB, l-THP and haloperidol. Scopolamine reversed the antagonistic effect of THB against amphetamine. Thus, THB and l-THP exhibited the DA-receptor antagonistic property which was similar to that of haloperidol. l-SPD (10 mg/kg), however, only antagonized the amphetamine-challenged rotational response, while it could not antagonize, but potentiate, the apomorphine-challenged rotational response. So, l-SPD might be a partial agonistic antagonist of DA-receptors, and its effect was more potent than that of THB and l-THP. l-SPD would be ascertained further in clinic trial. From these results and others, the authors suggest that THPB is a new chemical type of antagonist of brain DA-receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880397

Source DB:  PubMed          Journal:  Sci Sin B        ISSN: 0253-5823


  10 in total

Review 1.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 2.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

4.  An alternative synthesis and x-ray crystallographic confirmation of (-)-stepholidine.

Authors:  Satishkumar V Gadhiya; Chunhua Hu; Wayne W Harding
Journal:  Tetrahedron Lett       Date:  2016-05-11       Impact factor: 2.415

5.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

6.  Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.

Authors:  Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-20       Impact factor: 3.205

7.  Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.

Authors:  Taehyun Kim; David J Hinton; Sandy Johng; Jia Bei Wang; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

8.  Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.

Authors:  Sudharshan Madapa; Satishkumar Gadhiya; Thomas Kurtzman; Ian L Alberts; Steven Ramsey; Maarten Reith; Wayne W Harding
Journal:  Eur J Med Chem       Date:  2016-09-14       Impact factor: 6.514

9.  Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.

Authors:  John R Mantsch; Shi-Jiang Li; Robert Risinger; Sarah Awad; Eric Katz; David A Baker; Zheng Yang
Journal:  Psychopharmacology (Berl)       Date:  2007-03-15       Impact factor: 4.415

10.  The neuropharmacology of (-)-stepholidine and its potential applications.

Authors:  Kechun Yang; Guozhang Jin; Jie Wu
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.